Global Precision Cardiology Market Outlook, 2029

The Global Precision Cardiology Market is estimated to have a staggering growth , driven by Shift Towards Personalized Medicine.

According to publisher, Here is the Global Precision Cardiology Market Report. Market Insights The global precision cardiology market is experiencing significant growth, driven by several key factors. Rising Cardiovascular Disease Burden: Cardiovascular diseases (CVDs) are the leading cause of death globally, with an estimated 17.9 million deaths in 2019. This growing burden fuels demand for early detection and personalized treatment approaches. Increased Awareness of Early Screening: Public health initiatives and advancements in technology are raising awareness about the importance of early screening for CVDs. This creates a larger market for precision cardiology services and products. Reduced Cost of Sequencing Technologies: Next-generation sequencing (NGS) is a crucial tool in precision cardiology for identifying genetic variations linked to heart disease. As NGS costs decrease, it becomes more accessible, propelling market growth. Market Dynamics The market is characterized by the following dynamics: Shift Towards Personalized Medicine: Precision cardiology aligns perfectly with the growing trend of personalized medicine, which tailors treatments to individual patients based on their unique genetic makeup. Technological Advancements: Continuous advancements in genomics, bioinformatics, and artificial intelligence (AI) are creating more sophisticated tools for risk prediction, diagnosis, and treatment of CVDs. Growing Focus on Preventative Care: The healthcare industry is shifting towards preventative measures, and precision cardiology offers an effective way to identify patients at high risk for developing CVDs before symptoms appear.

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

Market Segments The market can be segmented by: Offering: Services (genetic testing, interpretation) and Products (diagnostic kits, sequencing platforms) Sample Type: Blood, Non-blood (saliva, buccal swabs) Technology: Sequencing (NGS, Sanger sequencing), Polymerase Chain Reaction (PCR), Microarray Application: Cardiomyopathy, Arrhythmia, Aortopathy and Vascular Diseases, Familial Hypercholesterolemia (FH), Congenital Heart Defects and Syndromes End-User: Hospitals and Diagnostic Laboratories, Academic and Research Institutes Regional Analysis The global market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. As of 2021, North America held the largest market share due to well-developed healthcare infrastructure and high adoption rates of new technologies. However, the Asia Pacific region is expected to witness the fastest growth rate due to factors like rising disposable incomes, increasing awareness about CVDs, and growing government investments in healthcare. Key Developments Strategic Partnerships: Leading players are forming strategic collaborations with academic institutions and research organizations to develop and commercialize novel precision cardiology solutions. Product Launches: Companies are actively launching new products to address specific unmet needs in the market. For instance, Illumina introduced the TruSight Cardio Sequencing Panel, a comprehensive NGS test for identifying genetic variants associated with various heart conditions. Regulatory Approvals: Regulatory bodies like the US Food and Drug Administration (FDA) are approving new precision cardiology tests and technologies, further accelerating market growth. Competitive Landscape

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant

The competitive landscape is characterized by a mix of established players and emerging companies. Some key players include: Illumina (US) Thermo Fisher Scientific (US) Roche Diagnostics (Switzerland) Abbott Laboratories (US) Myriad Genetics (US) These companies are actively engaged in research and development, product launches, and strategic partnerships to expand their market share.

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

Table of Contents

  • Table Of Contents
  • Figures And Tables
  • Part 1. Introduction
  • 1.1 Description
  • 1.2 Objectives Of The Study
  • 1.3 Market Segment
  • 1.4 Years Considered For The Report
  • 1.5 Currency
  • 1.6 Key Target Audience
  • Part 2. Research Methodology
  • 2.1 Primary Research
  • 2.2 Secondary Research
  • Part 3. Executive Summary
  • Part 4. Market Overview
  • 4.1 Introduction
  • 4.2 Drivers
  • 4.3 Restraints
  • Part 5. Global Precision Cardiology Market By Component
  • 5.1 Service
  • 5.2 Product
  • Part 6. Global Precision Cardiology Market By Sample
  • 6.1 Blood
  • 6.2 Saliva
  • 6.3 Buccal Swabs
  • 6.4 Other Non-Blood
  • Part 7. Global Precision Cardiology Market By Technology
  • 7.1 Next-Generation Sequencing (Ngs)
  • 7.2 Sanger Sequencing
  • 7.3 Polymerase Chain Reaction (Pcr)
  • 7.4 Microarray
  • 7.5 Others
  • Part 8. Global Precision Cardiology Market By Application
  • 8.1 Cardiomyopathy
  • 8.2 Arrhythmia
  • 8.3 Aortopathy And Vascular Diseases
  • 8.4 Familial Hypercholesterolemia (Fh)
  • 8.5 Congenital Heart Defects And Syndromes
  • 8.6 Others
  • Part 9. Global Precision Cardiology Market By End User
  • 9.1 Hospitals
  • 9.2 Institutes
  • 9.3 Others
  • Part 10. Global Precision Cardiology Market By Region
  • 10.1 North America
  • 10.2 Europe
  • 10.3 Asia-Pacific
  • 10.4 Mea (Middle East And Africa)
  • 10.5 Latin America
  • Part 11. Company Profiles
  • 11.1 Illumina, Inc.
  • 11.2 Genincode Plc
  • 11.3 Perkinelmer, Inc.
  • 11.4 Thermo Fisher Scientific Inc.
  • 11.5 Laboratory Corporation Of America Holdings
  • 11.6 Invitae Corporation
  • 11.7 Opko Health, Inc. (Opk)
  • 11.8 Centogene N.V.
  • 11.9 Eurofins Scientific Se
  • 11.10 Exact Sciences Corporation
  • 11.11 Fulgent Genetics, Inc.
  • 11.12 Konica Minolta, Inc.
  • 11.13 Orasure Technologies, Inc.
  • 11.14 Quest Diagnostics Incorporated
  • 11.15 Sema4 Opco, Inc.
  • 11.16 Devyser Diagnostics Ab
  • 11.17 Associated Regional And University Pathologists, Inc.
  • Disclaimer

Logo

Global Precision Cardiology Market Outlook, 2029

Contact usWe are friendly and approachable, give us a call.